Linical Co

Linical Co EPS

The Earnings per Share (EPS) of Linical Co (2183.T) as of Nov 10, 2026 is -147.41 JPY. In the previous year, Earnings per Share (EPS) was -23.87 JPY — a change of 517.61% (lower).

EPS

-147.41JPY

YoY

517.61%

Last updated:

Earnings per Share (EPS) of Linical Co is 2026 -147.41 JPY. Earnings per Share (EPS) of Linical Co was 2025 -23.87 JPY. It decreases by 517.61% lower compared to the previous year.

The Linical Co EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2020
21.38 JPY
Jan 1, 2021
23.91 JPY
Jan 1, 2022
35.00 JPY
Jan 1, 2023
44.47 JPY
Jan 1, 2024
14.98 JPY
Jan 1, 2025
-23.87 JPY
Jan 1, 2026
-147.41 JPY
Jan 1, 2027 (e)
29.70 JPY
The Linical Co EPS history
YEAREPSYoY
est29.70JPY-120.15%
-147.41JPY+517.61%
-23.87JPY-259.37%
14.98JPY-66.32%
44.47JPY+27.06%
35.00JPY+46.40%
23.91JPY+11.80%
21.38JPY-15.03%
25.17JPY-56.14%
57.38JPY-9.92%
63.70JPY+8.92%
58.48JPY+204.68%
19.19JPY-2.59%
19.70JPY-27.19%
27.06JPY+45.38%
18.61JPY+186.80%
6.49JPY-48.53%
12.61JPY+3.77%
12.15JPY+1.35%
11.99JPY+137.53%
5.05JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Linical Co Stock analysis

What does Linical Co do? Linical Co., Ltd. generates revenue through two distinct business segments, the CRO segment and the Pharmaceutical Sales Support segment. The CRO segment provides contract monitoring, quality management, and consulting services specifically for phase II and phase III in drug development processes. These services are delivered to pharmaceutical companies as part of pharmaceutical contract research projects. The Pharmaceutical Sales Support segment focuses on the downstream market by providing pharmaceutical sales support for medical institutions. The company operates these businesses from its headquarters in Osaka, Osaka-Fu, leveraging its workforce of 759 full-time employees to deliver these specialized services. Linical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Linical Co stock

Earnings per Share (EPS) of Linical Co is -147.41 JPY in 2026.

Earnings per Share (EPS) of Linical Co changed from -23.87 JPY to -147.41 JPY, representing a 517.61% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Linical Co since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Linical Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Linical Co